Astellas' lawsuit against Prescrire: French court rules that prescrire did not "denigrate" protopic (tacrolimus).
A Paris court handed down its ruling on 2 March, rejecting a suit brought by pharmaceutical company Astellas against the French journal Prescrire. At a time when French society is reeling in the wake of the scandal caused by weight-loss drug Mediator (benfluorex), the 2 March ruling comes as very good news for healthcare professionals and for patients.